Indication(s): Chronic gout in adult patients refractory to conventional therapy. The expanded approval was based on data from the phase 4 MIRROR trial, which evaluated Krystexxa plus methotrexate in ...

Methotrexate falls into the category of disease-modifying antirheumatic drugs, or DMARDs. These drugs do more than deal with symptoms; they actually slow down progression of the disease. About 60 ...

Please provide your email address to receive an email when new articles are posted on . “The disease-modifying anti-rheumatic drug methotrexate is the standard-of-care treatment of inflammatory ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Split-dose methotrexate had greater efficacy and reduced the need for additional disease-modifying ...

Disease-modifying drug therapies are being sought intensively for osteoarthritis (OA), but none have proved out thus far. A previous trial in patients with OA of the hand had found that methotrexate ...

Methotrexate is widely prescribed for arthritis, psoriasis, and certain cancers. Here’s what patients need to know about ...

Patients who take methotrexate for a variety of immune-mediated inflammatory diseases and pause taking the drug following receipt of a COVID-19 vaccine dose did not have a higher risk of disease flare ...

When Becky Schwarz saw the message in her patient portal saying she could no longer receive a prescription for methotrexate to treat her lupus, she felt surprised. It was only six days after the U.S.